YPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 14 EUR -1.41% Market Closed

Market Cap: €25.1B

A	Astellas Pharma Inc DUS:YPH	JP
B	Bumi Resources Minerals Tbk PT XMUN:BUR	ID
	Grupo Aeroportuario del Sureste SAB de CV F:AED	MX
P	Prada SpA DUS:PRP	IT
	ESR-REIT F:UZ00	SG
	Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC PAR:CCN	FR
	CIMB Group Holdings Bhd OTC:CIMDF	MY
L	Lonza Group AG XMUN:LO3	CH
	Microstrategy Inc BMV:MSTR	US
	Nomura Research Institute Ltd F:NR7	JP
	Bellsystem24 Holdings Inc TSE:6183	JP
J	JCDecaux SE F:DCS	FR

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

10% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

4% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.